Notification about latest news from us.
Kimberly-Clark announces a $48.7 billion acquisition of Tylenol maker Kenvue, facing scrutiny over controversial claims linking Tylenol to autism.
The U.S. and AMD team up for $1 billion supercomputer initiative set to revolutionize AI and scientific research.
Uruguay legalizes euthanasia, allowing assisted dying for terminally ill patients, marking a historic shift in healthcare rights.
House Speaker Mike Johnson warns the U.S. government shutdown could extend into the longest in history, centering on healthcare policy disputes.
Trump reveals a new deal with AstraZeneca to offer substantial discounts on prescription drugs for Americans, continuing efforts to lower drug prices.
TrumpRx aims to reduce prescription medication costs for Americans but faces skepticism over its potential effectiveness.
The US government has shut down, furloughing 750,000 federal workers as Congress fails to reach a funding agreement, leading to heightened political tensions.
Trump's new deal with Pfizer aims to cut drug prices and launch TrumpRx for direct-to-consumer sales, promoting economic benefits.
Lenacapavir to be available at $40 annually, enhancing accessibility in over 120 countries by 2027.
Concerns rise over U.S. doctor shortages as Trump's new H-1B visa fee may restrict access to skilled healthcare professionals.
By clicking send you'll receive occasional emails from newsletters about this topic.